Duloxetine, Pregabalin, and Duloxetine Plus Gabapentin for Diabetic Peripheral Neuropathic Pain Management in Patients With Inadequate Pain Response to Gabapentin: An Open-Label, Randomized, Noninferiority Comparison
Authors:
- Gordon A. IrvingGIGordon A. Irving
- Richard C. RisserRRRichard C. Risser
- Jonna AhlJAJonna Ahl
- Michael J. RobinsonMRMichael J. Robinson
- Vladimir SkljarevskiVSVladimir Skljarevski
- Sandra K. MalcolmSMSandra K. Malcolm
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 86 (7) , 615-626
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Pregabalin in the Treatment of Refractory Neuropathic Pain: Results of a 15-Month Open-Label TrialPain Medicine, 2008
- Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: A randomized, double‐blind studyEuropean journal of pain, 2008
- Pharmacologic management of neuropathic pain: Evidence-based recommendationsPain, 2007
- A randomized controlled trial of duloxetine in diabetic peripheral neuropathic painNeurology, 2006
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2006
- Pain Severity in Diabetic Peripheral Neuropathy is Associated with Patient Functioning, Symptom Levels of Anxiety and Depression, and SleepJournal of Pain and Symptom Management, 2005
- A Double-Blind, Randomized Multicenter Trial Comparing Duloxetine with Placebo in the Management of Diabetic Peripheral Neuropathic PainPain Medicine, 2005
- Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimensPain, 2005
- Relief of painful diabetic peripheral neuropathy with pregabalin: A randomized, placebo-controlled trialThe Journal of Pain, 2005
- Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agentsThe American Journal of Medicine, 2000